Skip to main content
Braster S.A. logo

Braster S.A. — Investor Relations & Filings

Ticker · BRA ISIN · PLBRSTR00014 LEI · 259400GV3T3LOS094487 WAR Manufacturing
Filings indexed 1,512 across all filing types
Latest filing 2023-02-17 M&A Activity
Country PL Poland
Listing WAR BRA

About Braster S.A.

https://www.braster.eu/en

Braster S.A. is a medical technology company specializing in the development, production, and marketing of diagnostic devices for breast health. Its core product is the Braster System, a medical device designed for regular, in-home breast examination. The system utilizes a proprietary contact thermography method with liquid crystal technology to monitor temperature distribution within the breasts. It functions by detecting and recording areas of elevated temperature, which may indicate pathological changes. The Braster device is intended as a non-invasive, complementary screening tool to be used by women as an adjunct to standard diagnostic procedures such as mammography and ultrasound, promoting systematic breast health monitoring.

Recent filings

Filing Released Lang Actions
Podpisanie porozumienia o współpracy w zakresie farmy fotowoltaicznej "Serby" - Content (PL)
M&A Activity Classification · 95% confidence The document text describes a formal agreement (porozumienie) signed between Bras S.A. and EHN S.A. regarding cooperation on photovoltaic farm projects, specifically concerning grid connection, energy sales, and investor acquisition. This type of announcement details a significant business transaction or strategic partnership that impacts the company's operations and future structure. It is not a standard financial report (10-K, IR, ER), a management change (MANG), or a director's trade (DIRS). It most closely aligns with an announcement regarding a major business transaction or strategic development. Given the options, 'M&A Activity' (TAR) is often used broadly for significant corporate transactions, but this is a cooperation agreement, not a merger or takeover bid. 'Regulatory Filings' (RNS) is a general fallback. However, since this details a specific strategic agreement impacting future projects and financing potential, it fits best under a category related to corporate actions or strategic developments. Since there isn't a specific 'Strategic Partnership' code, and it's a formal announcement of a business deal, I will evaluate if it fits 'Capital/Financing Update' (CAP) or 'Regulatory Filings' (RNS). As it is a specific agreement about project development and cooperation rather than a direct financing event or M&A, RNS (General Regulatory Filings) is the most appropriate fallback for a specific, non-standard corporate action announcement, although 'TAR' (M&A Activity) is sometimes used loosely for major deals. Given the nature of cooperation on project development, RNS is safer than misclassifying it as M&A.
2023-02-17 Polish
Terminy publikacji raportów okresowych Spółki w 2023 roku - Content (PL)
Report Publication Announcement Classification · 100% confidence The document text is very short (555 characters) and explicitly states the schedule ('terminy przekazywania') for the release of various periodic reports (annual, quarterly, semi-annual) for the upcoming year (2023). It is not the report itself, but an announcement about when the reports will be published. This aligns perfectly with the definition of a Report Publication Announcement (RPA), which covers announcements regarding the timing or release of company reports.
2023-01-30 Polish
GP_Notyfikacja.Art19Mar_2_1_2023.pdf
Director's Dealing Classification · 99% confidence The document is titled "Powiadomienie o transakcji/transakcjach*, o którym mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of a transaction(s) referred to in Article 19(1) of the MAR Regulation). Article 19 of the Market Abuse Regulation (MAR) specifically deals with transactions conducted by persons discharging managerial responsibilities (PDMRs). The content details transactions (Nabycie/Acquisition and Objęcie w wyniku zamiany/Subscription following conversion) involving shares and bonds by an individual identified as a member of the Supervisory Board (Przewodniczący Rady Nadzorczej). This type of insider transaction reporting by directors/executives directly corresponds to the definition of Director's Dealing (DIRS).
2023-01-03 Polish
AD_Notyfikacja.Art19Mar_2_1_2023.pdf
Director's Dealing Classification · 100% confidence The document is titled "Powiadomienie o transakcji/transakcjach*, o którym mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of a transaction/transactions referred to in Article 19(1) of the MAR Regulation). Article 19 of the Market Abuse Regulation (MAR) specifically deals with transactions conducted by persons discharging managerial responsibilities (PDMRs). The content details transactions (acquisition/subscription and conversion of bonds into shares) made by 'Artur Drobniak', identified as a 'członek zarządu' (member of the management board). This clearly indicates a report of personal share transactions by a company director/executive, which corresponds directly to the definition of Director's Dealing (DIRS). The document length is moderate (6408 chars), suggesting it is the actual filing, not just an announcement of a filing.
2023-01-03 Polish
Informacja o transakcji dokonanej przez osobę pełniącą obowiązki zarządcze przekazana w trybie art. 19 Rozporządzenia MAR. - Content (PL)
Director's Dealing Classification · 98% confidence The document text is very short (481 characters) and reports on transactions made by a Member of the Management Board (Członek Zarządu) and the Chairman of the Supervisory Board (Przewodniczący Rady Nadzorczej) involving the acquisition of bonds and their subsequent conversion into common shares. This describes personal share transactions by company directors/executives (insider trades). The text explicitly states that the content of the notifications is provided 'in the attachment' ('w załączeniu'), suggesting this is an announcement about insider transactions rather than the full regulatory filing itself. Therefore, the most appropriate classification is Director's Dealing (DIRS).
2023-01-03 Polish
Zamiana obligacji serii B6 na akcje Emitenta - Content (PL)
Share Issue/Capital Change Classification · 99% confidence The document discusses the conversion of bonds (obligacji) into shares (akcje), resulting in a conditional increase in the company's share capital. It details the number of shares issued, the new total share capital amount, and the resulting total number of votes. This action directly relates to changes in the company's capital structure and financing instruments (bonds being converted to equity). This aligns best with the 'Capital/Financing Update' category (CAP), as it is a specific event detailing a capital structure change resulting from a financing instrument conversion, rather than a general announcement of fundraising (CAP) or a simple share repurchase (POS). It is not a general regulatory filing (RNS) because it is highly specific to a capital event.
2022-12-29 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.